Core Laboratories Inc.
CLB
$13.16
-$0.03-0.19%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -115.95% | -65.25% | 33.88% | 7,006.49% | -102.08% |
| Total Depreciation and Amortization | 2.62% | 2.06% | -2.07% | -1.26% | 1.45% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -79.12% | 290.63% | -158.20% | -130.68% | 583.69% |
| Change in Net Operating Assets | 91.48% | -86.83% | -465.74% | 153.29% | -123.43% |
| Cash from Operations | -50.10% | -6.54% | -38.94% | 109.05% | -67.69% |
| Capital Expenditure | -33.93% | -20.53% | 29.99% | -20.93% | 18.31% |
| Sale of Property, Plant, and Equipment | 123.20% | 339.47% | -84.27% | -21.46% | 53.37% |
| Cash Acquisitions | -- | -- | 100.00% | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 106.08% | -102.81% | 125.74% | -25.18% | 15,505.00% |
| Cash from Investing | 9.62% | -256.79% | 245.56% | -312.95% | 121.69% |
| Total Debt Issued | 450.00% | 9.09% | -8.33% | -7.69% | 116.67% |
| Total Debt Repaid | -287.50% | 20.00% | -66.67% | 20.00% | 25.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -50.49% | 46.98% | -82.88% | -35.46% | 58.77% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 1.29% | -0.22% | 0.85% | 0.00% | 0.00% |
| Other Financing Activities | -- | 100.05% | -19,900.00% | 11.11% | -- |
| Cash from Financing | 93.58% | 56.72% | -414.51% | 28.65% | 76.86% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 104.00% | 47.35% | -161.22% | 207.83% | 227.32% |